Single versus Dual Antiplatelet Therapy after Left Atrial Appendage Closure: a Propensity Score Matching Analysis

Heart, Artery and Coronary Diseases

Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry

Heart

von Koch S, Koul S, Grimfjärd P, Andersson J, Jernberg T, Omerovic E, Fröbert O, Erlinge D, A Mohammad M

doi: 10.1136/heartjnl-2024-324307

Atrial FibrillationFurther Publications

Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial

Circ Cardiovasc Interv

Fanaroff AC, Wojdyla DM, Granger CB, Goodman SG, Aronson RS, Windecker S, Mehran R, Alexander JH, Lopes RD

doi: 10.1161/CIRCINTERVENTIONS.123.013596

Heart, Artery and Coronary Diseases

De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials

Lancet

Valgimigli M, Hong SJ, Gragnano F, Chalkou K, Franzone A, da Costa BR, Baber U, Kim BK, Jang Y, Chen SL, Stone GW, Hahn JY, Windecker S, Gibson MC, Song YB, Ge Z, Vranckx P, Mehta S, Gwon HC, Lopes RD, Dangas GD, McFadden EP, Angiolillo DJ, Leonardi S, Heg D, Calabrò P, Jüni P, Mehran R, Hong MK, Single Versus Dual Antiplatelet Therapy (Sidney-4) collaborator group

doi: 10.1016/S0140-6736(24)01616-7

Atrial FibrillationTherapy and Intervention

Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial

Am Heart J

Gosvig K, Goller J, Hansson NH, Brandes A, Modrau I, Rasmussen LF, Eskesen K, Jensen AKG, Belley-Côté E, Whitlock R, Riber LPS

doi: 10.1016/j.ahj.2025.04.015

Atrial FibrillationThrombosis and Stroke

Long-term outcomes after echocardiography versus fluoroscopy-guided left atrial appendage closure: Is there still a role for a simplified approach?

Catheter Cardiovasc Interv

Gilhofer TS, Schweiger V, Gehler M, Bokemeyer V, Chen M, Candreva A, Würdinger M, Di Vece D, Templin C, Niederseer D, Stähli BE, Stehli J, Gotschy A, Jakob P, Ruschitzka F, Binder R, Nietlispach F, Michel J, Kasel AM

doi: 10.1002/ccd.31126

Heart, Artery and Coronary DiseasesTherapy and Intervention

Temporal Trends, Outcomes, and Predictors of Next-Day Discharge and Readmission Following Uncomplicated Evolut Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis

J Am Heart Assoc

Batchelor WB, Sanchez CE, Sorajja P, Harvey JE, Galper BZ, Kini A, Keegan P, Grubb KJ, Eisenberg R, Rogers T

doi: 10.1161/JAHA.123.033846

Atrial FibrillationThrombosis and Stroke

Left atrial appendage occlusion: trends in demographics and in-hospital outcomes-a German nationwide analysis

Clin Res Cardiol

Voran JC, Seoudy H, Leye M, Kolbrink B, Schulte K, Dempfle A, Frank D, Kreidel F

doi: 10.1007/s00392-024-02586-0

Atrial FibrillationHeart Failure

Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis

Heart Rhythm

Bulhões E, Antunes VLJ, Mazetto R, Defante MLR, Garcia AC, Guida C

doi: 10.1016/j.hrthm.2024.04.058

Atrial FibrillationHeart, Artery and Coronary Diseases

Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials

J Am Coll Cardiol

Rashedi S, Keykhaei M, Sato A, Steg PG, Piazza G, Eikelboom JW, Lopes RD, Bonaca MP, Yasuda S, Ogawa H, Shizuta S, Kimura T, Okumura Y, Andreotti F, Bertoletti L, Stone GW, Mehran R, Cohen DJ, Lip GYH, Bikdeli B

doi: 10.1016/j.jacc.2024.12.030

Related content